• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The Worldwide Microbiology Market (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology)

$4,500.00 – $9,000.00

Clear
SKU: KLI15652532 Categories: Diagnostics Market Research, Immunoassays, Point-of-Care Diagnostics Pages: 272
  • Description
  • Table of Contents
  • Latest reports

Description

The Worldwide Microbiology Market (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology)

Microbiology has always been a major segment of the diagnostic market because the burden of infectious diseases is high. This important field is attracting even more attention today as the because of the large and growing problem of antibiotic resistance. The Worldwide Microbiology Market provides current market (2017) and market projections (to 2022) by segment (traditional microbiology, microbiology/infectious disease immunoassays, molecular microbiology, mass spectrometry in microbiology, total microbiology market), by pathogen/disease (healthcare-acquired infections / antimicrobial resistance, STDs / women’s health, hepatitis, HIV, respiratory tract infections, others), and by geographic region (North America, Western Europe, Japan, China, India, Latin America (incl. Mexico), rest of the world).

The report also looks at the global microbiology/infectious disease immunoassay 2017-2022 market by segment (laboratory-based immunoassays, rapid/point-of-care immunoassays, total microbiology/infectious disease immunoassay market), by geographic region (North America, Western Europe, Japan, China, India, Latin America (incl. Mexico), rest of the world), and by pathogen/disease indication (hepatitis, HIV, STDs, TORCH, respiratory, sepsis, parasitology, mycology, others).

There is a need for rapid tests that can quickly identify a microbial pathogen, and (if the pathogen is a bacteria) identify what antibiotic will be effective in treating the infection – all before a physician makes the treatment decision. This ideal test does not yet exist, but considerable advances are occurring in fields such as molecular microbiology and mass spectrometry in the microbiology laboratory. In addition, new technologies and platforms are being developed by companies that are working towards development of this much needed test. Beckman Coulter, Becton Dickinson, bioMérieux, and Thermo Fisher Scientific are among the market companies profiled in the report.91

Table of Contents

CHAPTER 1: EXECUTIVE SUMMARY

OVERVIEW

SCOPE AND METHODOLOGY

MARKET OVERVIEW

Table 1-1: Worldwide Microbiology Market, by Segment, 2017-2022 (in millions USD) (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology, Total Microbiology Market)

CHAPTER 2: INTRODUCTION

THE MICROBIOLOGY LABORATORY

TRADITIONAL MICROBIOLOGY – MICROBIAL IDENTIFICATION AND ANTIBIOTIC SUSCEPTIBILITY TESTING (ID/AST)

ADVANCES IN MICROBIOLOGY

THE QUEST FOR RAPID MICROBIAL IDENTIFICATION/ANTIBIOTIC SUSCEPTIBILITY (RESISTANCE) TESTS

Figure 2-1: Moving Towards the Goal of Rapid Microbial Identification and Antibiotic Resistance/Susceptibility Testing – Evolution towards a Platform that Combines Desired Characteristics of Different Technologies

Point-of-View and Methodology

CHAPTER 3: WHY CARE ABOUT WHAT IS HAPPENING IN MICROBIOLOGY? INFECTIOUS DISEASE TRENDS

BURDEN OF INFECTIOUS DISEASE

EMERGING THREATS

THE PROBLEM OF MICROBIAL ANTIBIOTIC RESISTANCE

LIMITATIONS OF TRADITIONAL MICROBIOLOGY

NEEDED: RAPID MICROBIAL IDENTIFICATION AND ANTIBIOTIC SUSCEPTIBILITY/RESISTANCE TESTS

CHAPTER 4: SELECTED TECHNOLOGIES/PLATFORMS IN MICROBIOLOGY LABORATORIES

TRADITIONAL MICROBIOLOGY

Overview of Traditional Microbial ID/AST

Table 4-1: Microbiology Sample/Specimen Types Ranked by Average Volume

ID/AST Systems, and Panels and Reagents for ID/AST Systems

Table 4-2: Major Companies Marketing Microbial ID/AST Systems

Chromogenic Media

Table 4-3: Selected Companies Marketing Chromogenic Media

Rapid Tests Performed on Colonies from Culture Media

Blood Culture

Table 4-4: Selected Companies Marketing Blood Culture Systems

MASS SPECTROMETRY

Table 4-5: Mass Spectrometry Companies in Microbiology

IMMUNOASSAYS

Traditional Rapid Immunoassay Technologies – Flow Through Assays and Immunochromatographic (Lateral Flow) Tests

Enzyme Immunoassays

POLYMERASE CHAIN REACTION AND OTHER NUCLEIC ACID AMPLIFICATION TECHNOLOGIES

Table 4-6: Selected Nucleic Acid Amplification Test and Other Molecular Companies in Microbiology

CHAPTER 5: ADVANCES IN THE MICROBIOLOGY LABORATORY

LIQUID MICROBIOLOGY AND ID/AST AUTOMATION

ADVANCES IN MICROBIAL IDENTIFICATION FOLLOWING BLOOD CULTURE

MASS SPECTROMETRY

PCR AND OTHER NAAT BASED TESTS FOR INFECTIOUS DISEASES

NEXT GENERATION SEQUENCING

Table 5-1: Selected Companies Applying DNA/RNA Sequencing to Microbiology

CHAPTER 6: APPLICATIONS AND ADVANCES IN MOLECULAR MICROBIOLOGY

APPLICATIONS OF MOLECULAR TESTING IN THE MICROBIOLOGY LABORATORY – SELECTED EXAMPLES

Sexually Transmitted Diseases and Women’s Health

Hepatitis

HIV

Hospital-Acquired Infections (HAIs)

Respiratory Infections

Tuberculosis

MULTIPLEX TESTS AND SYNDROMIC TESTING

What is Syndromic Testing and Why is ii Important?

When Should Syndromic Testing Be Performed? Syndromic Testing versus Traditional Single or Duplex Multiple Diagnostic Tests

DNA AND RNA SEQUENCING IN MICROBIOLOGY

CHAPTER 7: RAPID MICROBIOLOGY

“RAPID” TESTING IN MICROBIOLOGY LABS TODAY – FASTER THAN TRADITIONAL MICROBIOLOGY, BUT…

MAKING PROGRESS – DEVELOPMENT OF FASTER IDENTIFICATION AND ANTIMICROBIAL SUSCEPTIBILITY/RESISTANCE TESTS FOR THE MICROBIOLOGY LAB AND NEAR PATIENT OR POINT-OF-CARE

Table 7-1: Selected Companies Developing Faster Identification, Some Also with Antimicrobial Susceptibility/Resistance Tests

CHAPTER 8: CORPORATE DEALS IN MICROBIOLOGY

INVESTMENTS AND FINANCING AGREEMENTS

Table 8-1: Selected Investment and Financing Agreements in Microbiology

MERGER AND ACQUISITIONS

Table 8-2: Selected Acquisitions of Microbiology Companies

CORPORATE AGREEMENTS AND COLLABORATIONS

Table 8-3: Selected Agreements between Microbiology Companies and Other Companies

MICROBIOLOGY COMPANY COLLABORATIONS AND OTHER AGREEMENTS WITH UNIVERSITIES, NON-PROFIT RESEARCH INSTITUTES AND GOVERNMENT

Table 8-4: Selected Microbiology Company Agreements with Academia or Other Non-Profit Organizations

CHAPTER 9: MARKET DRIVERS, CHALLENGES, AND TRENDS IN MICROBIOLOGY

COST OF MOLECULAR MICROBIOLOGY TESTS VERSUS TRADITIONAL MICROBIOLOGY

CLINICAL MARKET DRIVERS

NEAR-PATIENT AND POINT-OF-CARE TESTING MARKET DRIVERS AND CHALLENGES/HURDLES

COMPETITION

REGULATION

REIMBURSEMENT

FUTURE PROSPECTS

CHAPTER 10: MICROBIOLOGY MARKET ANALYSIS

WORLDWIDE MICROBIOLOGY MARKET

Table 10-1: Worldwide Microbiology Market, by Segment, 2017-2022 (in millions USD) (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology, Total Microbiology Market)

Table 10-2: Major Pathogens/Disease Indications in Microbiology/Infectious Disease Market, 2017 (%) (Healthcare-Acquired Infections / Antimicrobial Resistance, STDs / Women’s Health, Hepatitis, HIV, Respiratory Tract Infections, Others)

Table 10-3: Worldwide Microbiology Market, by Geographic Region, 2017-2022 (in millions USD) (North America, Western Europe, Japan, China, India, Latin America, Rest of the World, Total Microbiology Market)

TRADITIONAL MICROBIOLOGY ID/AST MARKET

Microbial Identification and Antimicrobial Susceptibility Systems

Blood Culture

Chromogenic Media

Rapid Tests Performed on Colonies from Culture Media

Table 10-4: Worldwide Traditional Microbiology Market, by Segment, 2017-2022 (in millions USD) (Automated ID/AST Systems, Manual ID/AST Systems, Blood Culture, Chromogenic Media, Rapid Microbiology, Total Traditional Microbiology Market)

Table 10-5: Worldwide Traditional Microbiology Market, by Geographic Region, 2017-2022 (in millions USD) (North America, Western Europe, Japan, China, India, Latin America (incl. Mexico), Rest of the World, Total Traditional Microbiology Market)

Table 10-6: Market Shares of Selected Companies in the Traditional Microbiology Market (%)

MICROBIOLOGY/INFECTIOUS DISEASE IMMUNOASSAY MARKET

Table 10-7: Worldwide Microbiology/Infectious Disease Immunoassay Market, by Segment, 2017-2022 (in millions USD) (Laboratory-Based Immunoassays, Rapid/Point-of-Care Immunoassays, Total Microbiology/Infectious Disease Immunoassay Market)

Table 10-8: Worldwide Microbiology/Infectious Disease Immunoassay Market, by Geographic Region, 2017-2022 (in millions USD) (North America, Western Europe, Japan, China, India, Latin America (incl. Mexico), Rest of the World, Total Microbiology/Infectious Disease Immunoassay Market)

Table 10-9: Worldwide Clinical Laboratory-Based Microbiology/Infectious Disease Immunoassay Market, by Pathogen/Disease Indication, 2017 (in millions USD) (Hepatitis, HIV, STDs, TORCH, Respiratory, Sepsis, Parasitology, Mycology, Others [includes immunoassays for EBV, Chagas, Dengue, Malaria, etc.], Total)

Table 10-10: Worldwide Rapid Microbiology/Infectious Disease Immunoassay Market, by Pathogen/Disease Indication, 2017 (in millions USD) (Influenza, HIV, Malaria, Hepatitis, STDs [includes Chlamydia and syphilis], C. difficile, E. coli, Strep A, H. pylori, Home Test / OTC, Others, Total)

MOLECULAR MICROBIOLOGY MARKET

Table 10-11: Worldwide Molecular Microbiology Market, by Pathogen/Disease Indication, 2017-2022 (in millions USD) (Hepatitis, HIV, Healthcare Acquired Infections and Sepsis, Respiratory Pathogens, Sexually Transmitted Diseases and Women’s Health, Tuberculosis, Other, Total Worldwide Molecular Microbiology Market)

Table 10-12: Worldwide Molecular Microbiology Market, by Geographic Region, 2017-2022 (in millions USD) (North America, Western Europe, Japan, China, India, Latin America, Rest of the World, Total – World Molecular Microbiology Market)

Table 10-13: Major Company Market Shares in Molecular Microbiology Diagnostic Testing (%)

MICROBIOLOGY MASS SPECTROMETRY MARKET

Table 10-14: Worldwide Microbiology Mass Spectrometry Market, 2017-2022 (in millions USD)

FUTURE MARKET POTENTIAL FOR RAPID MICROBIAL IDENTIFICATION AND ANTIBIOTIC SUSCEPTIBILITY/RESISTANCE TESTS

CHAPTER 11: COMPANY PROFILES

3I DIAGNOSTICS, INC. (3IDX)

ABBOTT

Recent Revenue History

Table 11-1: Abbott Revenues (2014 – 2016, plus first 9 months of 2017) (millions USD)

Company Overview – With a Focus on Microbiology/Infectious Disease Diagnostics

ACCELERATE DIAGNOSTICS, INC.

Recent Revenue History

Table 11-2: Accelerate Diagnostics, Inc. (2014 – 2017) (thousands USD)

Company Overview

ATLAS GENETICS LTD.

AUTOGENOMICS, INC.

BECKMAN COULTER, INC. (A DANAHER CORPORATION COMPANY)

Revenue History

Company Overview

BECTON, DICKINSON AND COMPANY (BD)

Recent Revenue History

Table 11-3: Becton, Dickinson and Co. Revenues (FY2015 to FY2017) (millions USD)

Company Overview

BIO-RAD LABORATORIES, INC

Recent Revenue History

Table 11-4: Company Revenues (2014 – 2017) (thousands USD)

Company Overview

BIOFIRE DIAGNOSTICS, LLC. (ACQUIRED BY BIOMÉRIEUX)

Recent Revenue History and Other Financial Information

Company Overview

BIOMÉRIEUX SA

Recent Revenue History

Table 11-5: bioMérieux Revenues (2015-2017) (millions euros)

Company Overview

BRUKER CORPORATION

Recent Revenue History

Table 11-6: Bruker Corporation Revenues (2014 – 2017) (millions USD)

Company Overview:

CEPHEID (A DANAHER COMPANY)

Recent Revenue History

Table 11-7: Company Revenues (2013 – 2015, last year available) (thousands USD)

Company Overview

COPAN ITALIA S.P.A. AND COPAN DIAGNOSTICS, INC.

CURETIS

Recent Revenue History

Table 11-8: Curetis N.V. Revenues (2015 – 2017)

Company Overview

DIASORIN S.P.A.

Recent Revenue History

Table 11-9: DiaSorin Revenues (2015 – 2016, plus first nine months of 2017) (millions of euros)

Company Overview

ELITECH GROUP

GENEPOC INC.

GENMARK DIAGNOSTICS, INC.

Recent Revenue History

Table 11-10: GenMark Diagnostics Revenues (2014 – 2017) (thousands USD)

Company Overview

HOLOGIC, INC.

Recent Revenue History

Table 11-11: Hologic, Inc. Revenues (FY2015 – FY2017) (millions USD)

Company Overview

JANSSEN DIAGNOSTICS (JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON)

LUMINEX CORPORATION

Recent Revenue History

Table 11-12: Luminex Corporation Revenues (2014 – 2017) (thousands USD)

Company Overview

MAST GROUP

Q-LINEA AB

QIAGEN N.V.

Recent Revenue History

Table 11-13: Company Revenues (2015-2017) (thousands USD)

Company Overview

QUANDX INC.

QUANTUMDX GROUP

QUIDEL, INC.

Recent Revenue History

Table 11-14: Quidel Revenues (2015-2017) (thousands USD)

Company Overview

QVELLA CORPORATION

RHEONIX, INC.

ROCHE

Recent Revenue History

Table 11-15: Roche Revenues (2015-2017) (millions USD)

Company Overview

SIEMENS HEALTHINEERS

Recent Revenue History

Siemens Revenues (2016 – 2017) (millions euros)

Company Overview

THERMO FISHER SCIENTIFIC INC.

Recent Revenue History

Table 11-16: Thermo Fisher Scientific (2015-2017) (millions USD)

Company Overview

XAGENIC INC

 

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Molecular Diagnostics for Inherited Disease Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Molecular Imaging Agents and Systems – A Market Briefing

    $995.00 – $1,990.00
  • Placeholder image

    The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition

    $3,900.00 – $7,800.00
  • Placeholder image

    Clinical Diagnostics in India – Market Sector Analyses and Participant Directory

    $4,500.00 – $9,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Market for In Vitro Diagnostic Test Contract Manufacturing (OEM)IVD in China
Scroll to top